By Andrea Figueras Roche said that the European Commission approved Tecentriq SC, a cancer immunotherapy subcutaneous injection for multiple cancer types. The Swiss pharmaceutical company said Tuesday that…
Read more Roche's Cancer Injection Tecentriq SC Gets European Commission ApprovalBy Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The Swiss pharmaceutical company said Tuesday…
Read more Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage StudyBy David Sachs Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the early stage of the disease.…
Read more Roche Lung Cancer Drug Shows Promise in Phase 3 Trial
